{
    "organizations": [],
    "uuid": "4b5714e0ff2ee8237559e9a97c585246b215c509",
    "author": "",
    "url": "https://www.reuters.com/article/brief-therapix-biosciences-announces-exp/brief-therapix-biosciences-announces-expansion-into-precision-medicine-through-new-fully-owned-subsidiary-idUSASB0C0DG",
    "ord_in_thread": 0,
    "title": "BRIEF-Therapix Biosciences Announces Expansion Into Precision Medicine Through New Fully-Owned Subsidiary",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 9, 2018 / 1:47 PM / Updated 11 minutes ago BRIEF-Therapix Biosciences Announces Expansion Into Precision Medicine Through New Fully-Owned Subsidiary Reuters Staff 1 Min Read \nJan 9 (Reuters) - Therapix Biosciences Ltd: \n* THERAPIX BIOSCIENCES ANNOUNCES EXPANSION INTO PRECISION MEDICINE THROUGH NEW FULLY-OWNED SUBSIDIARY AND PROVIDES CORPORATE UPDATE TODAY AT THE BIOTECH SHOWCASE™ 2018 \n* THERAPIX BIOSCIENCES LTD - ‍EXPANDING INTO PRECISION MEDICINE THROUGH A NEW FULLY-OWNED SUBSIDIARY IN ORDER TO DEVELOP “NOVEL SOLUTIONS FOR PAIN”​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-09T15:44:00.000+02:00",
    "crawled": "2018-01-09T16:02:21.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "bioscience",
        "announces",
        "expansion",
        "precision",
        "medicine",
        "new",
        "subsidiary",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "therapix",
        "bioscience",
        "ltd",
        "therapix",
        "bioscience",
        "announces",
        "expansion",
        "precision",
        "medicine",
        "new",
        "subsidiary",
        "provides",
        "corporate",
        "update",
        "today",
        "biotech",
        "therapix",
        "bioscience",
        "ltd",
        "precision",
        "medicine",
        "new",
        "subsidiary",
        "order",
        "develop",
        "novel",
        "solution",
        "pain",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}